Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis

BACKGROUND: Asthma is a chronic disease characterized by airway hyperresponsiveness, inflammation and mucus production. In Type 2 asthma, two phenotypic components are often co-expressed (eosinophilic and allergic). Elevated biomarker levels, such as eosinophils (EOS), fraction of exhaled nitric oxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonica, Giorgio Walter, Blasi, Francesco, Crimi, Nunzio, Paggiaro, Pierluigi, Papi, Alberto, Fanelli, Francesca, Stassaldi, Annalisa, Furneri, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140446/
https://www.ncbi.nlm.nih.gov/pubmed/34020658
http://dx.doi.org/10.1186/s12948-021-00146-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140446/
https://www.ncbi.nlm.nih.gov/pubmed/34020658
http://dx.doi.org/10.1186/s12948-021-00146-9

Ejemplares similares